New Orleans Hospital Hosts 8,700 in 450 Cancer Trials

Patients across Louisiana no longer need to travel far from home to access the latest cancer treatments, thanks to a healthcare system bringing clinical trials directly to their communities.

Ochsner Health recently wrapped up its 23rd Annual Research Week, celebrating a milestone that matters for thousands of families. The Gulf South healthcare leader now runs 450 active clinical research trials with 8,700 participants, including 181 oncology studies available across eight cancer center locations in south Louisiana.

The numbers tell a story of expanding access. Through a partnership with UT MD Anderson, Ochsner offers innovative and early phase clinical trials that weren't previously available anywhere in the region. Patients can now receive cutting-edge care close to home instead of traveling hundreds of miles.

"We do clinical trials throughout the Gulf South, across our Research Centers of Excellence, offering the latest therapies where our patients live," said Dr. Leonardo Seoane, Ochsner's chief academic officer. The approach transforms how regional healthcare delivers hope to communities that historically faced geographic barriers to advanced treatment.

Research Week showcased the breadth of this work through presentations spanning colorectal cancer evolution, precision medicine using next-generation sequencing, and antibody-drug conjugates for gynecologic cancers. Dr. Marc Matrana highlighted how molecular and genomic tools now help doctors match patients to targeted therapies tailored to their specific cancer.

The event recognized excellence across 153 research abstracts submitted by doctors, residents, pharmacy researchers, and postdoctoral fellows. Twenty top presentations earned podium spots, while 96 were selected for poster sessions demonstrating the depth of scientific inquiry happening across the healthcare system.

The Ripple Effect

When major research happens in regional hospitals instead of just big city medical centers, entire communities benefit. Ochsner's approach means a parent in rural Louisiana can participate in a promising cancer trial without leaving their support system behind or draining savings on travel and lodging.

The healthcare system's commitment extends beyond cancer. Research spans health outcomes, pharmacy innovations, and population health, all focused on reflecting the needs of the people they serve. Three mentors received special recognition for guiding the next generation of researchers and strengthening the culture of discovery.

Access to clinical trials offers more than medical hope. It brings economic relief to families who would otherwise face impossible choices between experimental treatment and financial ruin from travel costs.

Louisiana now stands at the forefront of regional research innovation, proving that world-class medical discovery can happen where people already call home.